AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 3 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 8.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,000 | -90.0% | 218 | -81.9% | 0.00% | -100.0% |
Q4 2019 | $10,000 | +900.0% | 1,204 | +588.0% | 0.00% | – |
Q3 2019 | $1,000 | -50.0% | 175 | -44.8% | 0.00% | – |
Q2 2019 | $2,000 | -96.5% | 317 | -95.5% | 0.00% | -100.0% |
Q1 2019 | $57,000 | +50.0% | 7,083 | +38.4% | 0.01% | +66.7% |
Q4 2018 | $38,000 | +8.6% | 5,116 | +44.9% | 0.00% | 0.0% |
Q3 2018 | $35,000 | – | 3,531 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $258,000 | 3.49% |
Aisling Capital Management LP | 1,691,151 | $3,890,000 | 2.10% |
Sio Capital Management, LLC | 871,101 | $2,004,000 | 0.66% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $6,550,000 | 0.64% |
Samsara BioCapital, LLC | 883,720 | $2,033,000 | 0.51% |
Ghost Tree Capital, LLC | 686,599 | $1,579,000 | 0.34% |
Nantahala Capital Management | 3,200,593 | $7,361,000 | 0.33% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $565,000 | 0.29% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,059,894 | $9,338,000 | 0.28% |
Lion Point Capital, LP | 300,000 | $690,000 | 0.16% |